India
· Delayed Price · Currency is INR Torrent Pharmaceuticals Statistics
Total Valuation
Torrent Pharmaceuticals has a market cap or net worth of INR 1.18 trillion. The enterprise value is 1.21 trillion.
| Market Cap | 1.18T |
| Enterprise Value | 1.21T |
Important Dates
The next estimated earnings date is Friday, October 25, 2024.
| Earnings Date | Oct 25, 2024 |
| Ex-Dividend Date | Jun 21, 2024 |
Share Statistics
Torrent Pharmaceuticals has 338.45 million shares outstanding. The number of shares has increased by 0.06% in one year.
| Shares Outstanding | 338.45M |
| Shares Change (YoY) | +0.06% |
| Shares Change (QoQ) | -0.03% |
| Owned by Insiders (%) | 0.01% |
| Owned by Institutions (%) | 15.06% |
| Float | 96.61M |
Valuation Ratios
The trailing PE ratio is 68.22 and the forward PE ratio is 53.90. Torrent Pharmaceuticals's PEG ratio is 2.11.
| PE Ratio | 68.22 |
| Forward PE | 53.90 |
| PS Ratio | 10.77 |
| PB Ratio | 17.27 |
| P/FCF Ratio | n/a |
| PEG Ratio | 2.11 |
Enterprise Valuation
| EV / Earnings | 69.96 |
| EV / Sales | 11.04 |
| EV / EBITDA | 34.72 |
| EV / EBIT | 44.98 |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 0.59 |
| Debt / EBITDA | 1.16 |
| Debt / FCF | n/a |
| Interest Coverage | 8.32 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Capital (ROIC) | 14.99% |
| Revenue Per Employee | 7.00M |
| Profits Per Employee | 1.10M |
| Employee Count | 15,718 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +87.33% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | +87.33% |
| 50-Day Moving Average | 3,396.42 |
| 200-Day Moving Average | 2,847.24 |
| Relative Strength Index (RSI) | 55.22 |
| Average Volume (20 Days) | 3,806 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Torrent Pharmaceuticals had revenue of INR 109.96 billion and earned 17.35 billion in profits. Earnings per share was 51.27.
| Revenue | 109.96B |
| Gross Profit | 82.66B |
| Operating Income | 26.99B |
| Pretax Income | 24.77B |
| Net Income | 17.35B |
| EBITDA | 34.74B |
| EBIT | 26.99B |
| Earnings Per Share (EPS) | 51.27 |
Balance Sheet
The company has 10.04 billion in cash and 40.39 billion in debt, giving a net cash position of -30.35 billion or -89.69 per share.
| Cash & Cash Equivalents | 10.04B |
| Total Debt | 40.39B |
| Net Cash | -30.35B |
| Net Cash Per Share | -89.69 |
| Equity (Book Value) | 68.56B |
| Book Value Per Share | 202.58 |
| Working Capital | n/a |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 75.17%, with operating and profit margins of 24.55% and 15.78%.
| Gross Margin | 75.17% |
| Operating Margin | 24.55% |
| Pretax Margin | 22.53% |
| Profit Margin | 15.78% |
| EBITDA Margin | 31.60% |
| EBIT Margin | 24.55% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 28.00, which amounts to a dividend yield of 0.80%.
| Dividend Per Share | 28.00 |
| Dividend Yield | 0.80% |
| Dividend Growth (YoY) | 27.27% |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.06% |
| Shareholder Yield | 0.74% |
| Earnings Yield | 1.47% |
| FCF Yield | n/a |
Stock Splits
The last stock split was on July 8, 2022. It was a forward split with a ratio of 2.
| Last Split Date | Jul 8, 2022 |
| Split Type | Forward |
| Split Ratio | 2 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |